Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.
Authors: Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pepe F; Department of Public Health, Federico II University of Naples, Naples, Italy., Negrelli M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; School of Pathology, University of Milan, Milan, Italy., Olmeda E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; School of Pathology, University of Milan, Milan, Italy., Vacirca D; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ranghiero A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Malapelle U; Department of Public Health, Federico II University of Naples, Naples, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: nicola.fusco@ieo.it.
Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep; Vol. 201, pp. 104427. Date of Electronic Publication: 2024 Jun 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0461
DOI:10.1016/j.critrevonc.2024.104427